ask="5.89"
ask_size="500"
average_daily_volume="1484880"
bid="5.58"
bid_size="500"
book_value="0.21"
change="-0.39"
change_from_200_day_moving_average="0.16"
change_from_50_day_moving_average="-0.30"
change_from_52_week_high="-2.16"
change_From_52_week_low="2.53"
change_in_percent="-6.47%"
close="5.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71327000"
high="6.03"
high_52_weeks="7.80"
last_trade_date="1/19/2017"
last_trade_price="5.64"
last_trade_size="54760"
last_trade_time="4:00pm"
low="5.64"
low_52_weeks="3.11"
market_capitalization="597.61M"
moving_average_200_day="5.48"
moving_average_50_day="5.94"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.02"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+2.99%"
percent_change_from_50_day_moving_average="-5.04%"
percent_change_from_52_week_high="-27.69%"
percent_change_from_52_week_low="+81.35%"
previous_close="6.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="28.99"
price_per_sales="22.63"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="16.17"
stock_exchange="NCM"
symbol="KERX"
volume="2170591"
weeks_range_52="3.11 - 7.80"
